At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
FlowTriever2 Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
FlowTriever Pulmonary Embolectomy Clinical Study - FlowTriever2
In Brief
A clinical study evaluating FlowTriever2 Catheter for Pulmonary Embolism. Completed, enrolled 50 participants across 7 sites.
Detailed Summary
The FLARE-FT2 confirmatory study is a prospective, single-arm, multicenter study of the FlowTriever2 Catheter for mechanical thrombectomy of pulmonary embolism (PE).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Embolism
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedSep 2022
Enrollment StartFeb 2023
Primary CompletionSep 2024
TodayJul 2026
First PostedSep 29, 2022
Enrollment StartFeb 14, 2023
Primary CompletionSep 9, 2024
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 3.8 years ago
Interventions
FlowTriever2 Catheterdevice
The FlowTriever2 Catheter is utilized for the treatment of Pulmonary Embolism via mechanical thrombectomy of thrombus in the pulmonary arteries.